Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,239
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
for
Marginal Zone Lymphoma
Location: Nashvile TN, Atlanta GA, Miami FL, Duarte CA
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT05296070
Phase 2, Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,
Location: Nashville TN, Atlanta GA, Cincinnati OH,
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
for
Endothelial Dysfunction
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 18 - 60
Code: NCT04769206
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Nashville TN, Birmingham AL, Memphis TN, Atlanta GA,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase 2, Recruiting
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
for
Cardiac Failure, Graft Rejection
Location: Nashville TN, Charleston SC, Dallas TX, Boston MA,
Sponsor: Northwestern University
Sex: All
Age: 18 - 70+
Code: NCT06939751
Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Nashville TN, Atlanta GA, Cincinnati OH, Little Rock AR,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase 2, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Nashville TN, Bridgeton MO, Hinsdale IL, Chicago IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase 3, Recruiting
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1